Nicoderm: Clinical Trials

11 trials of Nicoderm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 terminated, 1 withdrawn. 11 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 211Completed 9, Terminated 1, Withdrawn 1
Phase 11Completed 1
Phase 31Terminated 1

Follow Nicoderm: new trials by email Literature Review of Nicoderm trials Research Report on Nicoderm

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products
Nicotine patch, Placebo patch, E-cigarettes - Nicotine Dependence, Cigarettes
Phase 2CompletedDuke University942018-08-062023-02-08
Electronic Nicotine Delivery Systems as a Smoking Cessation Treatment
Nicotine patch, ENDS, Placebo patch - Nicotine Dependence
Phase 2WithdrawnDuke University2018-07-012018-09-12
Combination Nicotine Patch / Lorcaserin for Smoking Cessation
lorcaserin, nicotine patch, placebo lorcaserin - Nicotine Dependence
Phase 2CompletedDuke University972016-11-082019-05-07
Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement
Nicotine patch, Nicotine mouthspray - Tobacco Use Disorder, Nicotine Dependence
Phase 2 / Phase 3TerminatedCentre for Addiction and Mental Health182015-07-012018-07-19
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Nicotine Patch, Moclobemide - Nicotine Dependence
Phase 2CompletedJed E. Rose762013-09-012017-08-23
Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate
Ganaxolone, Nicotine Patch - Smoking Cessation
Phase 2CompletedJed E. Rose362013-06-012014-09-08
Meclizine as a Potential Smoking Cessation Treatment
Meclizine, Nicotine Patch, Placebo - Smoking Cessation
Phase 2CompletedDuke University1462011-08-012014-08-01
Impact of Smoking Cessation and γ-Tocopherol to Restore Vascular Endothelial Function
Nicotine Replacement Therapy (NRT), Gamma-Tocopherol, Placebo - Endothelial Dysfunction
Phase 1 / Phase 2CompletedUniversity of Connecticut672011-01-012015-01-21
Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use
Usual Care Group, Reduction Group - Tobacco Use Disorder
Phase 2CompletedUniversity of Minnesota3322006-11-012017-10-16
Comparing Smoking Treatment Programs for Lighter Smokers - 1
nicotine transdermal system, bupropion, Medication Management - Tobacco Use Disorder
Phase 2CompletedUniversity of Pennsylvania2602003-09-012019-08-06
Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
Nicotine Replacement Therapies, Nicotine patch, Folic Acid - Smoking Cessation, Tobacco Use Disorder
Phase 2CompletedNational Institute on Drug Abuse (NIDA)1282002-04-012017-01-10

Conditions studied

Smoking Cessation (8)  ·  Tobacco Use Disorder (8)  ·  Cigarette Smoking (4)  ·  Vaping (2)

Sponsors

Duke University (4)  ·  Jed E. Rose (2)  ·  Centre for Addiction and Mental Health (1)  ·  National Institute on Drug Abuse (NIDA) (1)  ·  University of Connecticut (1)  ·  University of Minnesota (1)  ·  University of Pennsylvania (1)

Countries

United States (10)  ·  Canada (1)

Top investigators

Jed E Rose, Ph.D. (4)  ·  Jed E. Rose, Ph.D. (2)  ·  Dorothy Hatsukami, Ph.D. (1)  ·  Dorothy Hatsukami, PhD (1)  ·  James M Davis, M.D. (1)  ·  Laurie Zawertailo, PhD (1)  ·  Peter Selby, MBBS (1)  ·  Peter W Gariti, Ph.D. (1)  ·  Richard S Bruno, PhD, RD (1)

Results publications

PMID 19339135, PMID 22218402, PMID 24075893, PMID 25361769, PMID 31589323, PMID 34611902, PMID 37230961

NIH funding

P50DA027840 (5), R01DA014404 (1), R01DA015365 (1)